Patient Equity Capital is a Virtue

Patient Equity Capital is a Virtue

July 8, 2026 · 27 min · Episode 279

About this episode

Dan Nathan and Guy Adami discuss market volatility, AI funding, and the implications of recent IPOs.

Dan Nathan and Guy Adami open the podcast by framing the day’s key market story as sharp weakness and heightened volatility in memory, chips, and semi equipment, citing rapid reversals in names like Micron and Applied Materials and opaque guidance from Samsung. They discuss whether the AI build-out is increasingly debt-funded—highlighting Amazon and Oracle debt issuance and private credit deals—and reference a “Groundbreaker” piece shared by Jim Chanos arguing investors miss second-derivative slowdowns and that AI resembles a credit-driven real estate cycle more like 2008 than 2000’s patient equity bubble. They note a rotation bounce into software (Microsoft, Palantir, Salesforce, Adobe, ServiceNow) but question sustainability, and debate SpaceX’s fast-tracked inclusion in the Nasdaq 100 after its IPO, the stock’s poor trading, possible broader IPO implications, and an upcoming insider share unlock —FOLLOW USYouTube: @RiskReversalMediaInstagram: @riskreversalmediaTwitter: @RiskReversalLinkedIn: RiskReversal Media The financial opinions expressed in Risk Reversal content are for information purposes only. The opinions expressed by the hosts and participants are not an attempt to…

People in this episode

Hosts: Dan Nathan, Guy Adami

Topics covered

Keywords

Mentioned in this episode

Organizations: Micron, Applied Materials, Samsung, Amazon, Oracle, Jim Chanos, Microsoft, Palantir, Salesforce, Adobe

More episodes of RiskReversal Pod

Explore listener stats, chart rankings, contacts and more on the RiskReversal Pod podcast page.